LMAT — Lemaitre Vascular Income Statement
0.000.00%
Last trade - 00:00- $2.07bn
- $1.94bn
- $219.86m
- 96
- 11
- 78
- 65
Annual income statement for Lemaitre Vascular, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 129 | 154 | 162 | 193 | 220 |
| Cost of Revenue | |||||
| Gross Profit | 84.6 | 101 | 105 | 127 | 151 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 101 | 118 | 135 | 157 | 168 |
| Operating Profit | 28.8 | 36.4 | 26.8 | 36.7 | 52.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 27.4 | 34.3 | 27.5 | 39.5 | 56.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 21.2 | 26.9 | 20.6 | 30.1 | 44 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 21.2 | 26.9 | 20.6 | 30.1 | 44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 21.2 | 26.9 | 20.6 | 30.1 | 44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.02 | 1.25 | 1.04 | 1.36 | 1.93 |
| Dividends per Share |